Sipai Health Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	259.15	252.92	495.43	1,455	535.85
Short-Term Investments	114.6	95.34	155.85	75.15	5.05
Trading Asset Securities	244.25	571.52	478.35	-	1,067
Cash & Short-Term Investments	618	919.77	1,130	1,531	1,608
Cash Growth	-32.81%	-18.58%	-26.20%	-4.83%	-3.77%
Accounts Receivable	363.16	457.92	461.54	336.88	285.96
Other Receivables	-	15.59	25.24	27.33	22.15
Receivables	363.16	520.99	528.76	388.82	308.11
Inventory	67.15	193.53	246.06	280.33	269.04
Other Current Assets	214.26	345.84	538.03	495.59	302.88
Total Current Assets	1,263	1,980	2,442	2,695	2,488
Property, Plant & Equipment	31.37	57.74	81.11	88.86	113.8
Long-Term Investments	274.95	175.06	184.09	1.97	1.64
Goodwill	-	16.56	50.65	79.82	79.82
Other Intangible Assets	22.39	27.34	48.19	56.18	61.53
Long-Term Deferred Tax Assets	0.23	1.06	1.06	-	-
Long-Term Deferred Charges	-	-	-	-	6.89
Other Long-Term Assets	11.39	7.41	7.48	7.38	140.91
Total Assets	1,603	2,265	2,815	2,930	2,893

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	118.63	412.93	464.75	342.43	238.39
Accrued Expenses	-	163.36	141.29	126.33	129.4
Short-Term Debt	-	-	2	-	-
Current Portion of Leases	9.97	19.73	26.22	29.02	34.12
Current Income Taxes Payable	0.04	1.5	0.07	1.39	1.46
Current Unearned Revenue	223.79	188.75	181.9	170.72	167.29
Other Current Liabilities	337.83	250.35	325.71	385.44	260.15
Total Current Liabilities	690.26	1,037	1,142	1,055	830.8
Long-Term Debt	-	-	-	-	7,435
Long-Term Leases	12.61	25.76	39.34	38.75	52.9
Long-Term Deferred Tax Liabilities	0.03	1.33	2.62	1.34	1.52
Other Long-Term Liabilities	-	-	-	-	3.68
Total Liabilities	702.9	1,064	1,184	1,095	8,324

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.52	0.52	0.52	0.52	0.14
Retained Earnings	-	-	-7,436	-7,180	-5,810
Treasury Stock	-	-	-61.23	-0.08	-0.08
Comprehensive Income & Other	935.8	1,225	9,116	9,017	380.35
Total Common Equity	936.31	1,226	1,619	1,837	-5,429
Minority Interest	-36.31	-24.29	12.29	-2.77	-1.69
Shareholders' Equity	900.01	1,202	1,631	1,834	-5,431
Total Liabilities & Equity	1,603	2,265	2,815	2,930	2,893

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	22.58	45.49	67.56	67.76	7,522
Net Cash (Debt)	595.42	874.28	1,062	1,463	-5,914
Net Cash Growth	-31.90%	-17.68%	-27.40%	-	-
Net Cash Per Share	0.99	1.37	1.65	13.01	-59.46
Filing Date Shares Outstanding	749.49	764.18	761.5	763.03	219.2
Total Common Shares Outstanding	749.49	764.18	761.5	763.03	219.2
Working Capital	572.3	943.51	1,301	1,640	1,657
Book Value Per Share	1.25	1.60	2.13	2.41	-24.77
Tangible Book Value	913.92	1,182	1,520	1,701	-5,571
Tangible Book Value Per Share	1.22	1.55	2.00	2.23	-25.41
Machinery	-	12.2	18.77	19.79	20.95
Construction In Progress	-	0.56	0.87	0.37	0.34
Leasehold Improvements	-	27.53	31.45	42.62	42.98